FSD Pharma to Conduct Raise Near All Time Low

FSD Pharma (CSE: HUGE) continued its relentlessly investor-friendly actions last night, after posting financials late in the evening, followed by a twelve AM press release to announce that it would be conducting a raise a penny off its all time low. In total, the company generated just $18,501 in revenue during the quarter – rental income – while managing to blow through over $990,000 in advertising alone.

FSD Pharma Logo
FSD Pharma Logo

Total expenses for the quarter consisted of $9.80 million, of which $5.38 million consisted of share based payments. General and administrative expenses were next on the list, at $1.51 million, followed by the aforementioned advertising at $0.99 million. Salaries and wages were the fourth largest expense, at $0.91 million. In total, FSD Pharma lost $14.24 million over the three month period, or $0.01 per share.

Total cash consumed over the quarter amounted to $7.26 million. As of June 30, 2019, FSD had $9.84 million remaining in the till. Which leads us to the next topic of discussion – the raise announced this morning.

FSD Pharma is currently in the process of raising US$5 million, to be used towards the operations of recently acquired Prismic Pharma. With units priced at $0.10 each, approximately 66.33 million shares will be issued in connection with the offering. The kicker, is that despite being a penny off the 52 week low price for the equity, no warrants are being offered with the financing.

As a result, the firm has attempted to round up investor support by indicating that C$1.3 million has already been sourced for funding, of which over C$1.1 million is from members of management. FSD expects the financing to close by the end of September.

FSD Pharma is currently trading at $0.10 on the Canadian Securities Exchange.


Information for this briefing was found via Sedar and FSD Pharma. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Baselode Energy To Acquire Forum Energy: The Merger Of Equals Deal

TriStar Gold: The Revised Castelo de Sonhos Prefeasibility Study

Gold is Up 30%, But the Real Bull Market is Only Starting Now! | Adrian Day

Recommended

ESGold To Expand Mine Building At Montauban In Advance Of Gold & Silver Production

Goliath Resources Expands 2025 Drill Program To 60,000 Metres

Related News

FSD Pharma Commences Nasdaq Trading January 9, 2020

Much to the disbelief of many, it has finally happened. FSD Pharma (CSE: HUGE) (NASDAQ:...

Monday, January 6, 2020, 09:02:11 AM

Market Movers: FSD Pharma Climbs 46% in Intraday Trading

FSD Pharma (CSE: HUGE) has experienced a massive run up this week on the back...

Tuesday, January 7, 2020, 03:36:46 PM

FSD Pharma and World Class Extraction Cancel Agreement, Enter Letter of Intent for Joint Venture

FSD Pharma (CSE: HUGE) announced this morning a revised agreement with that of World Class...

Wednesday, September 25, 2019, 09:46:06 AM

FSD Pharma Announces 1 for 201 Share Consolidation

FSD Pharma (CSE: HUGE) announced this morning that it will be completing a share consolidation...

Friday, October 11, 2019, 09:04:28 AM

FSD Pharma Receives Much Awaited Sales License

FSD Pharma (CSE: HUGE) shareholders received some much awaited news this past weekend in the...

Tuesday, April 23, 2019, 07:30:15 AM